S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
3 Financially Fit Airline Stocks Worth Boarding
Should You Buy The Dip In JPMorgan (NYSE: JPM) Stock?
United Health’s Guidance Gives Investors A Chill 
New York AG says Trump's company misled banks, tax officials
German leader champions new tack on climate at Davos event
Colorado coal town grapples with future as plant shuts down
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
3 Financially Fit Airline Stocks Worth Boarding
Should You Buy The Dip In JPMorgan (NYSE: JPM) Stock?
United Health’s Guidance Gives Investors A Chill 
New York AG says Trump's company misled banks, tax officials
German leader champions new tack on climate at Davos event
Colorado coal town grapples with future as plant shuts down
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
3 Financially Fit Airline Stocks Worth Boarding
Should You Buy The Dip In JPMorgan (NYSE: JPM) Stock?
United Health’s Guidance Gives Investors A Chill 
New York AG says Trump's company misled banks, tax officials
German leader champions new tack on climate at Davos event
Colorado coal town grapples with future as plant shuts down
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
3 Financially Fit Airline Stocks Worth Boarding
Should You Buy The Dip In JPMorgan (NYSE: JPM) Stock?
United Health’s Guidance Gives Investors A Chill 
New York AG says Trump's company misled banks, tax officials
German leader champions new tack on climate at Davos event
Colorado coal town grapples with future as plant shuts down
CVE:MJN

Cronos Group Stock Forecast, Price & News

C$12.15
-0.23 (-1.86%)
(As of 03/2/2018)
Add
Compare
Today's Range
C$11.90
▼
C$12.47
50-Day Range
C$12.15
▼
C$12.15
52-Week Range
C$1.58
▼
C$14.83
Volume
1.39 million shs
Average Volume
2.07 million shs
Market Capitalization
C$1.73 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive MJN News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.


Cronos Group logo

About Cronos Group

Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals. Whistler Medical Marijuana is licensed to produce and sell medical marijuana, as well as cultivate cannabis oil. Hydropothecary is licensed to produce medical marijuana. Abcann Medicinals also has license to produce medical marijuana. With interest in five Licensed Producers and two LP applicants, it is focused on building brand portfolio providing patients with personalized care.

Headlines

Cronos Group (CVE:MJN) Stock Price Down 1.9%
January 15, 2022 |  americanbankingnews.com
Big Tobacco and Major US Stock Exchange Approval Further Boost Cannabis Sector Credibility
October 27, 2021 |  ca.finance.yahoo.com
MGC Pharmaceuticals reports record quarterly sales - Proactive Investors USA & Canada
July 26, 2021 |  proactiveinvestors.com
Edited Transcript of RB.L earnings conference call or presentation 24-Feb-21 8:00am GMT - Yahoo Finance
February 25, 2021 |  finance.yahoo.com
Cronos Group Changes Canadian Ticker to CRON
May 25, 2020 |  www.bloomberg.com
Cronos Group Files Q2 2017 Financial Results and Provides Operational Update
May 22, 2020 |  www.bloomberg.com
TSX:CRON (CRONOS GROUP)
March 22, 2020 |  www.fool.ca
TSX:AZ (ARMISTICE RESOURCES CORP.)
March 5, 2020 |  www.fool.ca
Canadian Medical Cannabis Sector Leading the Charge in Marijuana Industry Growth
February 11, 2020 |  www.bloomberg.com
Cronos Group Inc. Reports Q3 2017 Financial Results
October 24, 2019 |  www.bloomberg.com
Cronos Group (CRON) Dips More Than Broader Markets: What You Should Know - Nasdaq
March 20, 2019 |  www.nasdaq.com
Cronos Group Inc.(Nasdaq:CRON): Why investors should remain cautious about Canopy Growth (CGC) - StockNews.com
March 20, 2019 |  stocknews.com
Cronos Group Inc.(Nasdaq:CRON): Is Cronos Group (CRON) a Buy or Sell at this level? - StockNews.com
March 20, 2019 |  stocknews.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Electronic Computer Manufacturing
Sub-Industry
Cannabis
Sector
Manufacturing
Current Symbol
CVE:MJN
Previous Symbol
CUSIP
N/A
CIK
N/A
Web
thecronosgroup.com
Phone
+1-416-5040004
Fax
N/A
Employees
147,000
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
142,653,000
Free Float
N/A
Market Cap
C$1.73 billion
Optionable
Optionable

MarketRank™

Overall MarketRank™

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Cronos Group (CVE:MJN) Frequently Asked Questions

Is Cronos Group a good dividend stock?

Cronos Group pays an annual dividend of C$1.65 per share and currently has a dividend yield of 0.00%.

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:
  • Michael Ryan Gorenstein, President, Chief Executive Officer, Vice Chairman of the Board, Corporate Secretary
  • William Lawrence Hilson, Chief Financial Officer
  • Jason Adler, Director
  • Ryan Roebuck, Director
  • James Rudyk, Director
  • Alan Mark Friedman, Independent Director (Age 45)
  • Michael Howard Krestell, Independent Director

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), Canopy Growth (WEED), OrganiGram (OGI), Aphria (APHA), IMV (IMV), Leaf Mobile (LEAF), Aurora Cannabis (ACB) and CanniMed Therapeutics (CMED).

What is Cronos Group's stock symbol?

Cronos Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MJN."

How do I buy shares of Cronos Group?

Shares of MJN and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of MJN stock can currently be purchased for approximately C$12.15.

How much money does Cronos Group make?

Cronos Group has a market capitalization of C$1.73 billion.

How many employees does Cronos Group have?

Cronos Group employs 147,000 workers across the globe.

What is Cronos Group's official website?

The official website for Cronos Group is thecronosgroup.com.

Where are Cronos Group's headquarters?

Cronos Group is headquartered at 720 King St W Suite 320, TORONTO, ON M5V 2T3, Canada.

How can I contact Cronos Group?

Cronos Group's mailing address is 720 King St W Suite 320, TORONTO, ON M5V 2T3, Canada. The company can be reached via phone at +1-416-5040004.


This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.